EVREN TECHNOLOGIES, INC.

Newberry, FL · Founded 2018 · CIK 0001779895 · Medtech · Private

Transcutaneous auricular vagal nerve stimulation (taVNS) device for treating acute stress reactions

evrenvns.com →
Grants
$430K
2 awards
Sector median: 1
Raised
—
2 Form D · Oct 2023
35 months since last filing
Contracts
$172K
1 award · Defense
#469 of 4531 in medtech
Patents
2
0 granted · 2 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Personalized tVNS device for research and treatment of PTSD$256,581
Federal contract· 1 of 2 same dayDepartment of Defense · Medical Research And Development Purchase Order Army STTR Ph I Proposal No. A21C-T024-0283 Titled Transcutaneous Vagal Nerve Stimulation For Acute Stress Reactions.$171,786
Federal grant· 2 of 2 same dayDepartment of Defense · Phase I · Transcutaneous Vagal Nerve Stimulation for Acute Stress Reactions$172,993
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
466ANTA BIOTECHNOLOGIES CORPORATION$174K—
467TWINSTRAND BIOSCIENCES INC$174K$85M
468ISCIENCE INTERVENTIONAL CORP$174K$24M
469EVREN TECHNOLOGIES, INC.$172K—
470SPARK BIOMEDICAL INC.$171K$16M
471Assurex Health$171K—
472Gold Standard Diagnostics Corp.$167K$2.5M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Weaver GainesDirector · Executive Officer

Patents

USPTO · 0 granted of 2
  • Ear Device And Paired Treatments Involving Nerve Stimulationapplication
  • Ear Device And Paired Treatments Involving Nerve Stimulationapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.